Your Power to Heal
buy.svg
Where to buy
buy.svg
Where to buy
  • Image showing a packshot of Cutimed® Sorbion® Sorbact
  • Image showing Cutimed® Sorbion® Sorbact® from the top
  • Product facts visualizing high to excessive superficial infected
Image showing a packshot of Cutimed® Sorbion® Sorbact
Image showing Cutimed® Sorbion® Sorbact® from the top
Product facts visualizing high to excessive superficial infected

Cutimed® Sorbion® Sorbact®

is a bacteria and fungi binding wound dressing, based on Sorbact® Technology. It consists of a Sorbact® DACC™-coated wound contact layer combined with a superabsorbent core, which absorbs and retains excessive exudate levels, thereby optimising the wound environment.

  • Prevents and treats wound infection
  • Safe removal of bacteria, fungi and endotoxins 
  • Effective against most common resistant pathogens

Intended Purpose

Cutimed Sorbion Sorbact is intended for use in the management of clean, contaminated, colonised or infected high to excessive exuding wounds, such as pressure ulcers, diabetic foot ulcers, leg ulcers, traumatic wounds and surgical wounds. It is intended to be used on superficial wounds.

Wear time: Should the clinical condition allow, the dressing can be left in place for up to 7 days.

Product benefits

Symbol of a shield representing infection prevention

Prevents and treats wound infection

Sorbact Technology dressings reduce bioburden and support effective wound healing, with no known contraindications and low risk of allergies1, 2, 3, 4, 5, 6.
Symbol of looped threads to visualize the term 'pacify'

Safe removal of bacteria, fungi and endotoxins

Sorbact Technology dressings irreversibly bind and remove bacteria, without the release of active agents to the wound5. Development of bacterial or fungal resistance is not expected. 
Symbol showing crossed out pathogens, which stands for effectiveness against the most common resistant ones

Effective against most common resistant pathogens

In vitro tests show that Sorbact Technology dressings are able to inhibit the growth of the Top 5 World Health Organization (WHO) pathogens7.
Symbol with a weight on a wound to visualize the outstanding absorption capacity

Excellent absorption capacity

By absorbing and retaining wound exudate, the risk of maceration is reduced and a moist wound environment is enabled8.

Product facts

Superficial

Infected

High to excessive

Secondary fixation needed

How to use

Image showing how to apply Cutimed® Sorbion® Sorbact
1. Prepare the wound and surrounding skin according to local clinical practice.
2. Select an appropriate dressing size for the wound. The wound pad should overlap the wound margins by at least 2 cm. Do not cut the dressing.
3. Remove the dressing from the peel pouch using an aseptic technique.
4. Apply the dressing. Ensure that the green contact layer comes into direct contact with the complete wound surface to allow microorganisms to bind to the dressing.
5. Fixate with an elastic bandage or skin friendly tape. Ensure the dressing is allowed to expand under the fixation.
6. The dressing change frequency depends on exudate levels and the overall condition of the wound and surrounding skin. Should the clinical condition allow, the dressing can be left in place for up to 7 days.
How to remove
Should the dressing adhere to the wound, moisten the dressing to assist removal and to avoid disruption of the healing wound.

For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s Instructions for Use (IFU).

Product specifications

Product
Essity Product Code
Size
Pack Quantity
PIP Code
Cutimed® Sorbion® Sorbact® 7269800 10 cm x 10 cm 10 1 408-6815
Cutimed® Sorbion® Sorbact® 7269801 10 cm x 20 cm 10 1 408-6807
Cutimed® Sorbion® Sorbact® 7269802 20 cm x 20 cm 10 1 408-6823
Cutimed® Sorbion® Sorbact® 7269803 20 cm x 30 cm 10 1 408-6799

Medical References

1 Bua N et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017;44:387-392.
2 Stanirowski P et al. Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section. Surg Infect (Larchmt). 2016;17:427-435.
3 Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18.
4 Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-122, 124-127.
5 Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570.
6 Gentili V et al. Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed Sorbact. Eur J Clin Microbiol Infect Dis. 2012;31:1523-1529.
7 Husmark J et al. Antimicrobial effect of a DACC-coated bacteria-binding wound dressing against WHO pathogens. EWMA. November 18-19, 2020, virtual conference (EP006).
8 Abigo Medical AB. Data on file 2019 (DHF-4819-v.1.0). 

Would you like to find out more about this product and how it can help your patients?

Contact us

Clinical Evidence

On this page, you can view and explore a selection of clinical studies that underline the performance of the Cutimed portfolio.

Discover more

Instruction for use

Please make sure to always follow the instructions for use, including the safety information provided with the product. Not at hand? Find the needed safety information in this database!

Cutimed IFUs